vs

Side-by-side financial comparison of GEN Restaurant Group, Inc. (GENK) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

GEN Restaurant Group, Inc. is the larger business by last-quarter revenue ($49.7M vs $37.2M, roughly 1.3× Organogenesis Holdings Inc.). On growth, GEN Restaurant Group, Inc. posted the faster year-over-year revenue change (-9.0% vs -57.1%). Over the past eight quarters, GEN Restaurant Group, Inc.'s revenue compounded faster (-1.0% CAGR vs -46.5%).

Gen Korean BBQ is an American chain of all-you-can-eat Korean barbecue restaurants mainly concentrated around the Western U.S. It opened in 2011, and has since grown to 43 locations as of 2024.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

GENK vs ORGO — Head-to-Head

Bigger by revenue
GENK
GENK
1.3× larger
GENK
$49.7M
$37.2M
ORGO
Growing faster (revenue YoY)
GENK
GENK
+48.1% gap
GENK
-9.0%
-57.1%
ORGO
Faster 2-yr revenue CAGR
GENK
GENK
Annualised
GENK
-1.0%
-46.5%
ORGO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
GENK
GENK
ORGO
ORGO
Revenue
$49.7M
$37.2M
Net Profit
$-1.9M
Gross Margin
30.8%
Operating Margin
-24.5%
-185.1%
Net Margin
-3.8%
Revenue YoY
-9.0%
-57.1%
Net Profit YoY
-821.4%
EPS (diluted)
$-0.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GENK
GENK
ORGO
ORGO
Q1 26
$37.2M
Q4 25
$49.7M
$225.6M
Q3 25
$50.4M
$150.9M
Q2 25
$55.0M
$101.0M
Q1 25
$57.3M
$86.7M
Q4 24
$54.7M
$126.7M
Q3 24
$49.1M
$115.2M
Q2 24
$53.9M
$130.2M
Net Profit
GENK
GENK
ORGO
ORGO
Q1 26
Q4 25
$-1.9M
$43.7M
Q3 25
$-566.0K
$21.6M
Q2 25
$-261.0K
$-9.4M
Q1 25
$-301.0K
$-18.8M
Q4 24
$-206.0K
$7.7M
Q3 24
$25.0K
$12.3M
Q2 24
$277.0K
$-17.0M
Gross Margin
GENK
GENK
ORGO
ORGO
Q1 26
30.8%
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Operating Margin
GENK
GENK
ORGO
ORGO
Q1 26
-185.1%
Q4 25
-24.5%
28.1%
Q3 25
-7.4%
13.7%
Q2 25
-3.4%
-12.5%
Q1 25
-3.8%
-30.9%
Q4 24
-2.4%
8.1%
Q3 24
0.2%
5.4%
Q2 24
3.0%
-10.7%
Net Margin
GENK
GENK
ORGO
ORGO
Q1 26
Q4 25
-3.8%
19.4%
Q3 25
-1.1%
14.3%
Q2 25
-0.5%
-9.3%
Q1 25
-0.5%
-21.7%
Q4 24
-0.4%
6.1%
Q3 24
0.1%
10.7%
Q2 24
0.5%
-13.1%
EPS (diluted)
GENK
GENK
ORGO
ORGO
Q1 26
Q4 25
$-0.37
$0.31
Q3 25
$-0.11
$0.11
Q2 25
$-0.05
$-0.10
Q1 25
$-0.06
$-0.17
Q4 24
$-0.05
$0.05
Q3 24
$0.01
$0.09
Q2 24
$0.06
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GENK
GENK
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$2.8M
$91.4M
Total DebtLower is stronger
$13.6M
Stockholders' EquityBook value
$26.5M
Total Assets
$259.9M
$520.0M
Debt / EquityLower = less leverage
0.51×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GENK
GENK
ORGO
ORGO
Q1 26
$91.4M
Q4 25
$2.8M
$93.7M
Q3 25
$4.8M
$63.7M
Q2 25
$9.6M
$73.1M
Q1 25
$15.4M
$110.0M
Q4 24
$23.7M
$135.6M
Q3 24
$22.1M
$94.3M
Q2 24
$29.2M
$89.9M
Total Debt
GENK
GENK
ORGO
ORGO
Q1 26
Q4 25
$13.6M
Q3 25
$10.8M
Q2 25
$7.8M
Q1 25
$6.5M
Q4 24
$6.9M
Q3 24
$7.2M
$62.3M
Q2 24
$7.6M
$63.8M
Stockholders' Equity
GENK
GENK
ORGO
ORGO
Q1 26
Q4 25
$26.5M
$300.1M
Q3 25
$38.1M
$255.1M
Q2 25
$41.0M
$233.2M
Q1 25
$42.8M
$242.9M
Q4 24
$44.1M
$262.9M
Q3 24
$46.5M
$278.5M
Q2 24
$45.9M
$263.5M
Total Assets
GENK
GENK
ORGO
ORGO
Q1 26
$520.0M
Q4 25
$259.9M
$598.7M
Q3 25
$245.5M
$509.8M
Q2 25
$246.3M
$461.1M
Q1 25
$232.4M
$467.4M
Q4 24
$240.4M
$497.9M
Q3 24
$225.7M
$446.3M
Q2 24
$218.8M
$443.2M
Debt / Equity
GENK
GENK
ORGO
ORGO
Q1 26
Q4 25
0.51×
Q3 25
0.28×
Q2 25
0.19×
Q1 25
0.15×
Q4 24
0.16×
Q3 24
0.16×
0.22×
Q2 24
0.17×
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GENK
GENK
ORGO
ORGO
Operating Cash FlowLast quarter
$-426.0K
Free Cash FlowOCF − Capex
$-5.6M
FCF MarginFCF / Revenue
-11.3%
Capex IntensityCapex / Revenue
10.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-24.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GENK
GENK
ORGO
ORGO
Q1 26
Q4 25
$-426.0K
$39.4M
Q3 25
$-1.6M
$3.1M
Q2 25
$3.3M
$-32.9M
Q1 25
$2.2M
$-19.9M
Q4 24
$7.3M
$10.9M
Q3 24
$1.4M
$8.7M
Q2 24
$5.6M
$4.7M
Free Cash Flow
GENK
GENK
ORGO
ORGO
Q1 26
Q4 25
$-5.6M
$34.8M
Q3 25
$-7.7M
$844.0K
Q2 25
$-6.3M
$-36.5M
Q1 25
$-4.7M
$-23.6M
Q4 24
$165.0K
$7.6M
Q3 24
$-6.8M
$6.1M
Q2 24
$1.2M
$2.9M
FCF Margin
GENK
GENK
ORGO
ORGO
Q1 26
Q4 25
-11.3%
15.4%
Q3 25
-15.3%
0.6%
Q2 25
-11.5%
-36.1%
Q1 25
-8.2%
-27.2%
Q4 24
0.3%
6.0%
Q3 24
-13.9%
5.3%
Q2 24
2.3%
2.2%
Capex Intensity
GENK
GENK
ORGO
ORGO
Q1 26
Q4 25
10.5%
2.1%
Q3 25
12.0%
1.5%
Q2 25
17.5%
3.6%
Q1 25
11.9%
4.2%
Q4 24
13.1%
2.7%
Q3 24
16.9%
2.2%
Q2 24
8.0%
1.4%
Cash Conversion
GENK
GENK
ORGO
ORGO
Q1 26
Q4 25
0.90×
Q3 25
0.14×
Q2 25
Q1 25
Q4 24
1.43×
Q3 24
57.96×
0.71×
Q2 24
20.06×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons